Search Results - "Allemann, S."

Refine Results
  1. 1

    Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars - a prospective survey before and after the COVID-19 pandemic by Messner, Kirstin, Eickhoff, Christiane, Schulz, Martin, Allemann, Samuel S, Arnet, Isabelle

    Published in BMC health services research (18-12-2023)
    “…Knowledge, attitudes and substitution laws of biosimilars are not consistent across countries. Biosimilar acceptance among patients and healthcare…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Beyond Adherence Thresholds: A Simulation Study of the Optimal Classification of Longitudinal Adherence Trajectories From Medication Refill Histories by Allemann, Samuel S, Dediu, Dan, Dima, Alexandra Lelia

    Published in Frontiers in pharmacology (26-04-2019)
    “…The description of adherence based on medication refill histories relies on the estimation of continuous medication availability (CMA) during an observation…”
    Get full text
    Journal Article
  4. 4

    Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction by Wiss, Florine M, Allemann, Samuel S, Meyer Zu Schwabedissen, Henriette E, Stäuble, Céline K, Mikoteit, Thorsten, Lampert, Markus L

    Published in Frontiers in psychiatry (29-04-2024)
    “…Suspected adverse drug reactions (ADRs) during treatment with clozapine often prompt therapeutic drug monitoring (TDM) in clinical practice. Currently, there…”
    Get full text
    Journal Article
  5. 5

    Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study by Barbati, Selina, Strasser, Johannes, Allemann, Samuel S., Arnet, Isabelle

    Published in Health science reports (01-01-2024)
    “…Background and Aims The World Health Organization has set a goal to eradicate hepatitis C virus (HCV) by the year 2030. Nonadherence to HCV treatment has…”
    Get full text
    Journal Article
  6. 6

    Pharmacogenotyping disproves genetic cause of drug-related problems in family history: a case report by Bollinger, Anna, Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E., Allemann, Samuel S., Stäuble, Céline K.

    Published in BMC anesthesiology (15-11-2024)
    “…Background In clinical practice, family medication history is not routinely assessed as part of a patient's family health history (FHH). The information is…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting by Stäuble, Céline K, Jeiziner, Chiara, Bollinger, Anna, Wiss, Florine M, Hatzinger, Martin, Hersberger, Kurt E, Ihde, Thomas, Lampert, Markus L, Mikoteit, Thorsten, Meyer Zu Schwabedissen, Henriette E, Allemann, Samuel S

    Published in Pharmacy (19-07-2022)
    “…Genetic predisposition is one factor influencing interindividual drug response. Pharmacogenetic information can be used to guide the selection and dosing of…”
    Get full text
    Journal Article
  9. 9

    Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report by Jeiziner, Chiara, Allemann, Samuel S, Hersberger, Kurt E, Meyer Zu Schwabedissen, Henriette E

    Published in Pharmacogenomics and personalized medicine (31-05-2022)
    “…Pharmacogenetic (PGx) panel testing could help to determine the heritable component of a rheumatoid arthritis (RA) patient's susceptibility for therapy failure…”
    Get full text
    Journal Article
  10. 10

    Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database by Wittwer, Nina L, Meier, Christoph R, Huber, Carola A

    Published in Pharmacogenomics and personalized medicine (01-01-2022)
    “…Purpose: In Switzerland 167 drugs on the market contain information about pharmacogenetics in their drug label (PGx drug). Preemptive pharmacogenetic testing…”
    Get full text
    Journal Article
  11. 11

    Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study by Bollinger, Anna, Stäuble, Céline K, Jeiziner, Chiara, Wiss, Florine M, Hersberger, Kurt E, Lampert, Markus L, Meyer Zu Schwabedissen, Henriette E, Allemann, Samuel S

    Published in Pharmacogenomics and personalized medicine (01-01-2023)
    “…Pharmacogenetics (PGx) is an emerging aspect of personalized medicine with the potential to increase efficacy and safety of pharmacotherapy. However, PGx…”
    Get full text
    Journal Article
  12. 12

    Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial by Jenni, S, Oetliker, C, Allemann, S, Ith, M, Tappy, L, Wuerth, S, Egger, A, Boesch, C, Schneiter, Ph, Diem, P, Christ, E, Stettler, C

    Published in Diabetologia (01-08-2008)
    “…Aims/hypothesis We assessed systemic and local muscle fuel metabolism during aerobic exercise in patients with type 1 diabetes at euglycaemia and…”
    Get full text
    Journal Article
  13. 13

    Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials by Stettler, C, Allemann, S, Egger, M, Windecker, S, Meier, B, Diem, P

    Published in Heart (British Cardiac Society) (01-05-2006)
    “…Objective: To examine whether polymer based coronary stents eluting sirolimus or paclitaxel are equally effective in patients with and without diabetes…”
    Get full text
    Journal Article
  14. 14

    Eine Genealogie spanischen Rechtsdenkens by Allemann, Daniel S.

    “…Rafael Domingo, Javier Martínez-Torrón (Hg.), Great Christian Jurists in Spanish History (Cambridge Studies in Law and Christianity), Cambridge: Cambridge…”
    Get full text
    Journal Article
  15. 15

    QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus : a 23-year follow-up by STETTLER, C, BEARTH, A, ALLEMANN, S, ZWAHLEN, M, ZANCHIN, L, DEPLAZES, M, CHRIST, E. R, TEUSCHER, A, DIEM, P

    Published in Diabetologia (01-01-2007)
    “…We evaluated the association of QT interval corrected for heart rate (QT(c)) and resting heart rate (rHR) with mortality (all-causes, cardiovascular, cardiac,…”
    Get full text
    Journal Article
  16. 16

    Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case study by Allemann, Samuel S, Dürsteler, Kenneth M, Strasser, Johannes, Vogel, Marc, Stoeckle, Marcel, Hersberger, Kurt E, Arnet, Isabelle

    Published in Harm reduction journal (16-08-2017)
    “…Patients with substance use disorders grow older thanks to effective treatments. Together with a high prevalence of comorbidities, psychological problems, and…”
    Get full text
    Journal Article
  17. 17

    Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis by Amiesimaka, Obreniokibo Ibifubara, Allemann, Samuel S., Braund, Rhiannon, Schultz, Michael, Aluzaite, Kristina

    Published in British journal of clinical pharmacology (01-08-2024)
    “…Aims Inflammatory bowel disease (IBD) management entails long‐term medication therapy. Worse disease outcomes and reduced quality of life might arise from poor…”
    Get full text
    Journal Article
  18. 18

    Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: A data linkage study using dispensed prescriptions by Tan, Michael, Allemann, Samuel S., Qin, Xiwen Simon, D'Souza, Wendyl J.

    Published in Epilepsia (Copenhagen) (01-03-2023)
    “…Objective Medication adherence is considered an important risk factor for sudden unexpected death in epilepsy (SUDEP), although measurement accuracy is…”
    Get full text
    Journal Article
  19. 19

    Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene by Stäuble, Céline K., Meier, Rebecca, Lampert, Markus L., Mikoteit, Thorsten, Hatzinger, Martin, Allemann, Samuel S., Hersberger, Kurt E., Meyer zu Schwabedissen, Henriette E.

    Published in Frontiers in psychiatry (15-07-2022)
    “…We report the case of a 50-year-old male with major depressive disorder (MDD) to illustrate the challenge of finding effective antidepressant pharmacotherapy…”
    Get full text
    Journal Article
  20. 20

    Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting by Allemann, Samuel S, Hersberger, Kurt E, Arnet, Isabelle

    Published in Integrated pharmacy research and practice (01-01-2015)
    “…To collect opinions on medication management aids (MMAs) in general and on an electronic MMA (e-MMA) dispensing prepackaged polypharmacy in sealed pouches. The…”
    Get full text
    Journal Article